Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$7.61 - $9.46 $12,860 - $15,987
1,690 New
1,690 $14,000
Q3 2022

Oct 25, 2022

SELL
$16.06 - $26.39 $513 - $844
-32 Reduced 7.53%
393 $7,000
Q2 2022

Aug 04, 2022

SELL
$20.49 - $39.72 $348 - $675
-17 Reduced 3.85%
425 $9,000
Q1 2022

Apr 19, 2022

BUY
$28.19 - $46.6 $169 - $279
6 Added 1.38%
442 $16,000
Q4 2021

Feb 01, 2022

BUY
$41.2 - $73.6 $4,408 - $7,875
107 Added 32.52%
436 $20,000
Q3 2021

Oct 15, 2021

BUY
$59.15 - $91.99 $13,959 - $21,709
236 Added 253.76%
329 $21,000
Q2 2021

Aug 06, 2021

BUY
$63.02 - $95.11 $5,860 - $8,845
93 New
93 $9,000
Q3 2019

Nov 14, 2019

SELL
$20.03 - $40.08 $2,123 - $4,248
-106 Closed
0 $0
Q2 2019

Aug 07, 2019

BUY
$25.78 - $39.77 $2,732 - $4,215
106 New
106 $4,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.